Incidence and predictors of transthyretin cardiac amyloidosis in patients with degenerative aortic stenosis

Back

ESC Professional Premium Access

Incidence and predictors of transthyretin cardiac amyloidosis in patients with degenerative aortic stenosis

Session: When valvular heart disease is not alone

Topic: Aortic Valve Stenosis

Speaker: Professor W. Jaber (Cleveland, US)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Professor Wael Jaber

Cleveland Clinic Hospital, Cleveland (United States of America)

21 presentations

0 follower

6 more presentations in this session

Echocardiographic phenotype in severe aortic valve stenosis with and without cardiac amyloidosis: the AMY-TAVI trial.

Speaker: Professor J. Gonzalez Juanatey (Santiago de Compostela, ES)

Access

Abstract

Slides

Diagnostic performance of coronary CTA and CT-FFR for the detection of coronary artery disease in routine TAVI work-up

Speaker: Ms J. Peper (Nieuwegein, NL)

Access

Abstract

Slides

Revascularization of significant coronary artery disease in patients undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis

Speaker: Mr H. Aarts (Utrecht, NL)

Access

Abstract

Slides

Periprocedural outcomes of transcatheter aortic valve replacement (TAVR) in patients with and without cardiac amyloidosis-analysis from 2016-2019 national inpatient sample

Speaker: Doctor S. Kambalapalli (Flint, US)

Access

Abstract

Slides

Adding troponin to echocardiography improves preoperative abscess detection in infective endocarditis. A REMOVE Trial analysis

Speaker: Doctor M. Diab (Rotenburg An Der Fulda, DE)

Access

Abstract

Slides

Access the full session

When valvular heart disease is not alone

Speakers: Professor W. Jaber, Professor J. Gonzalez Juanatey, Ms J. Peper, Mr H. Aarts, Doctor S. Kambalapalli...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources